The meeting organised by the CFCD was rescheduled due to COVID19
It will take place in the Institut Necker Enfants Malades in PARIS form the 16 to 17th of December 2021.
Sanitary pass will be required for the participation to the meeting (Vaccination passport) or valid test results.
Click here for the final program and abstract book
FINAL PROGRAM CFCD 2021
Thursday December 16th, 2021
8:30 Opening of the registration desk
9:15 Welcome address
SESSION I – DC subsets
Chairpersons: Bénédicte Manoury and Marlène Dreux
9:30-9:55 Florent Ginhoux (France)
“The ever-expanding DC universe”?
10:00-10:25 Sophie Janssens (Belgium)
Dendritic cell maturation revisited
10:30-11:00 Coffee Break
11:00-11:25 Pierre Guermonprez (France)
DC subsets and T cell memory
11:30-12:15 Selected oral presentations
11:30-11:45 Stefanie Scheu (Germany)
The transcription factor BATF as novel regulator of type I interferon production in plasmacytoid dendritic cells
11:45-12:00 Andreas Schlitzer (Germany)
GPR183 dictates subtissular localisation of pulmonary CD301b+ conventional dendritic cells type 2 and instructs their survival via the TSLP – TSLP receptor axis
12:00-12:15 Javiera Villar (France)
ETV3 and ETV6 enable monocyte differentiation into dendritic cells during inflammation by repressing interferon-stimulated genes
12:15-12:45 Wolfgang Kastenmüller (Germany)
cDC1 maintain and guide the differentiation of TPEX cells in distinct cellular niches
12:45-15h30 LUNCH and Poster viewing
SESSION II – Tumor-associated macrophages and DCs
Chairpersons: Julie Helft and Paula Michea
15:30-15:55 Maria Casanova-Acebes (Spain)
Getting to know the origin of tumor-associated macrophages : challenges and opportunities for therapeutic intervention
16:00-16:25: Renato Ostuni (Italy)
Transcriptional control of tumor-associated macrophages
16:30-17:00 Selected oral presentations
16:30-16:45 Yohan Gerber-Ferder (France)
Breast cancer remotely remodel the hematopoietic niche favoring myelopoiesis and tumor growth
16:45-17:00 Margaux Huberti (France)
Spatial organization and prognostic impact of dendritic cell subsets in a large cohort of triple negative breast cancer patients
17:00-17:30 Kenneth Murphy (USA) videoconference
Genetic basis for divergence of DC progenitors[/I]
17:30 Cocktail
20:00 Speaker Dinner
Friday December 17th 2021
9:00 Opening of the registration desk
SESSION III – DCs and macrophages in tissues
[i]Chairpersons: Héléna Païdassi and Jérôme Martin
9:30-9:55 Melanie Greter (Switzerland) visioconférence
Macrophage development and function
10:00-10:25 Juliana Idoyaga (USA)
Emerging dendritic cell heterogeneity: the in-betweens
10:30 Coffee Break
11:00-11:45 Selected oral presentations
11:00-11:15 Maria-Graciela Delgado (France)
Formation of the myeloid compartment in vivo: Revealing an unexpected role for the Arp2/3 complex
11:15-11:30 Zhana Haimon (Israël) videoconference
Microglia interactions with T cells in relapsing remitting EAE
11:30-11:45 Antonin Weckel (USA)
Early life interactions between commensal bacteria and dermal CD301b+ cDC2s facilitate long-term immune tolerance to the skin microbiome
11:45-12:15 Santiago Zelenay (United Kingdom) videoconference
Manipulating inflammation to unleash cancer immune control
12:15-14:30 LUNCH and Poster viewing
14:30-14:45 CFCD General Assembly
SESSION IV – DCs in diseases
Chairpersons: Sophie Laffont and Vanja Sisirak
14:45-15:10 Brian Ruffel (USA) videoconference
Therapeutic targeting of intratumoral dendritic cells
15:15-15:40 Stephanie Eisenbarth (USA) videoconference
Cellular mechanics of DC migration
15:45-16:15 Selected oral presentations
15:45-16:00 Elena Winheim (Germany)
Yellow fever vaccination induces distinct and overlapping gene expression programs in human blood DC and monocyte subsets
16:00-16:15 Lucie Maisonneuve (France)
Regulation of IRE1α, an ER stress sensor, in dendritic cells
16:15-16h40 Vanja Sisirak (France)
Plasmacytoid dendritic cells promote DNA autoreactivity
16:45-17:10 Marlène Dreux (France)
Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2-infected cells
17h15 Award ceremony and concluding remarks
17:30 End of the meeting
It will take place in the Institut Necker Enfants Malades in PARIS form the 16 to 17th of December 2021.
Sanitary pass will be required for the participation to the meeting (Vaccination passport) or valid test results.
Click here for the final program and abstract book
FINAL PROGRAM CFCD 2021
Thursday December 16th, 2021
8:30 Opening of the registration desk
9:15 Welcome address
SESSION I – DC subsets
Chairpersons: Bénédicte Manoury and Marlène Dreux
9:30-9:55 Florent Ginhoux (France)
“The ever-expanding DC universe”?
10:00-10:25 Sophie Janssens (Belgium)
Dendritic cell maturation revisited
10:30-11:00 Coffee Break
11:00-11:25 Pierre Guermonprez (France)
DC subsets and T cell memory
11:30-12:15 Selected oral presentations
11:30-11:45 Stefanie Scheu (Germany)
The transcription factor BATF as novel regulator of type I interferon production in plasmacytoid dendritic cells
11:45-12:00 Andreas Schlitzer (Germany)
GPR183 dictates subtissular localisation of pulmonary CD301b+ conventional dendritic cells type 2 and instructs their survival via the TSLP – TSLP receptor axis
12:00-12:15 Javiera Villar (France)
ETV3 and ETV6 enable monocyte differentiation into dendritic cells during inflammation by repressing interferon-stimulated genes
12:15-12:45 Wolfgang Kastenmüller (Germany)
cDC1 maintain and guide the differentiation of TPEX cells in distinct cellular niches
12:45-15h30 LUNCH and Poster viewing
SESSION II – Tumor-associated macrophages and DCs
Chairpersons: Julie Helft and Paula Michea
15:30-15:55 Maria Casanova-Acebes (Spain)
Getting to know the origin of tumor-associated macrophages : challenges and opportunities for therapeutic intervention
16:00-16:25: Renato Ostuni (Italy)
Transcriptional control of tumor-associated macrophages
16:30-17:00 Selected oral presentations
16:30-16:45 Yohan Gerber-Ferder (France)
Breast cancer remotely remodel the hematopoietic niche favoring myelopoiesis and tumor growth
16:45-17:00 Margaux Huberti (France)
Spatial organization and prognostic impact of dendritic cell subsets in a large cohort of triple negative breast cancer patients
17:00-17:30 Kenneth Murphy (USA) videoconference
Genetic basis for divergence of DC progenitors[/I]
17:30 Cocktail
20:00 Speaker Dinner
Friday December 17th 2021
9:00 Opening of the registration desk
SESSION III – DCs and macrophages in tissues
[i]Chairpersons: Héléna Païdassi and Jérôme Martin
9:30-9:55 Melanie Greter (Switzerland) visioconférence
Macrophage development and function
10:00-10:25 Juliana Idoyaga (USA)
Emerging dendritic cell heterogeneity: the in-betweens
10:30 Coffee Break
11:00-11:45 Selected oral presentations
11:00-11:15 Maria-Graciela Delgado (France)
Formation of the myeloid compartment in vivo: Revealing an unexpected role for the Arp2/3 complex
11:15-11:30 Zhana Haimon (Israël) videoconference
Microglia interactions with T cells in relapsing remitting EAE
11:30-11:45 Antonin Weckel (USA)
Early life interactions between commensal bacteria and dermal CD301b+ cDC2s facilitate long-term immune tolerance to the skin microbiome
11:45-12:15 Santiago Zelenay (United Kingdom) videoconference
Manipulating inflammation to unleash cancer immune control
12:15-14:30 LUNCH and Poster viewing
14:30-14:45 CFCD General Assembly
SESSION IV – DCs in diseases
Chairpersons: Sophie Laffont and Vanja Sisirak
14:45-15:10 Brian Ruffel (USA) videoconference
Therapeutic targeting of intratumoral dendritic cells
15:15-15:40 Stephanie Eisenbarth (USA) videoconference
Cellular mechanics of DC migration
15:45-16:15 Selected oral presentations
15:45-16:00 Elena Winheim (Germany)
Yellow fever vaccination induces distinct and overlapping gene expression programs in human blood DC and monocyte subsets
16:00-16:15 Lucie Maisonneuve (France)
Regulation of IRE1α, an ER stress sensor, in dendritic cells
16:15-16h40 Vanja Sisirak (France)
Plasmacytoid dendritic cells promote DNA autoreactivity
16:45-17:10 Marlène Dreux (France)
Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2-infected cells
17h15 Award ceremony and concluding remarks
17:30 End of the meeting